Streetbeat News

Equity Actions

BGXX

DEA-licensed cannabis producer Bright Green Corporation (NASDAQ:BGXX) has closed a $3.5 million private placement of common stock and warrants. The company sold 3,684,210 shares of common stock and warrants at a purchase price of $0.95 per share and accompanying warrant. Gross proceeds are expected to be around $3.5 million before agent's fees and other expenses.

Portfolio Pulse from Maureen Meehan

May 24, 2023 | 10:42 pm

VRTS

Virtus Investment Partners has filed for a mixed shelf offering with the SEC, though the size of the offering has not been disclosed.

Portfolio Pulse from Charles Gross

May 24, 2023 | 9:25 pm

ASNS

Actelis Networks has filed a prospectus related to the offering of up to approximately 2 million shares of common stock by selling stockholders.

Portfolio Pulse from Charles Gross

May 24, 2023 | 9:22 pm

PSPC

Post Holdings Partnering Corporation (NYSE:PSPC) announced the redemption of all outstanding Series A common stock at approximately $10.24 per share, effective May 30, 2023. The last trading day for the Public Shares is expected to be May 26, 2023. The company will cease operations after May 28, 2023, and its securities will be delisted.

Portfolio Pulse from Happy Mohamed

May 24, 2023 | 8:39 pm

WSBF

Waterstone Financial has announced a 2 million share buyback program, which may lead to an increase in the stock price of WSBF.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 8:05 pm

QQQ

SPY

Benzinga's experiment, which pits OpenAI's ChatGPT against top-tier U.S. equity funds, enters its second week. ChatGPT's portfolio posted a gain of 0.25%, outpaced by six of the 10 leading funds, with T. Rowe Price Growth Stock Fund taking the lead at 1.42%. The experiment aims to investigate AI's potential as a supportive tool for making investment decisions.

Portfolio Pulse from AJ Fabino

May 24, 2023 | 6:21 pm

BDRX

Biodexa Pharmaceuticals announced a $3.32 million registered direct offering of 22,135,922 new American Depository Shares at $0.15 per share, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 5:31 pm

PHAT

Phathom Pharmaceuticals has resubmitted its FDA application for vonoprazan, an acid blocker for Erosive GERD, and raised $131M through an equity offering. The resubmission addresses concerns raised by the FDA in a Complete Response Letter.

Portfolio Pulse from Vandana Singh

May 24, 2023 | 4:31 pm

C

Citigroup plans to pursue an IPO of its consumer, small business, and middle-market banking operations in Mexico, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 4:18 pm

HASI

Hannon Armstrong Sustainable Infrastructure (HASI) announced a $300 million public offering of common stock, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2023 | 3:19 pm